Болезнь Фабри: особенности заболевания у детей и подростков
жүктеу/скачать 103,53 Kb. Pdf көрінісі
|
фарби
| J. Inherit. Metab. Dis
. 2006; 29: 106–111. Doi: 10.1007/ s10545-006-0196-0. 2. Germain D. P. Fabry disease. Orphanet J. Rare Dis . 2010; 5: 30. 3. Poorthuis B. J., Wevers R. A., Kleijer W. J., Groener J. E., de Jong J. G., van Weely S., Niezen-Koning K. E., van Diggelen O. P. The frequency of lysosomal storage diseases in The Netherlands. Hum. Genet. 1999; 105: 151–156. 4. Meikle P. J., Hopwood J. J., Clague A. E., Carrey W. F. Prevalence of lysosomal storage disorders. JAMA . 1999; 281: 249–254. Doi: 10.1001/jama.281.3.249. 5. Spada M., Pagliardini S., Yasuda M., Tukel T., Thiagarajan G., Sakuraba H., Ponzone A., Desnick R. J. High incidence of later-onset fabry disease revealed by newborn screening. Am. J. Hum. Genet. 2006; 79: 31–40. Doi: 10.1086/504601. 6. Lyon M. F. Gene action in the X-chromosome of the mouse (Mus musculus L.). Nature . 1961; 190: 372–373. 7. Eng C. M., Desnick R. J. Molecular basis of Fabry disease: muta- tions and polymorphisms in the human alpha-galactosidase A gene. Hum. Mutat . 1994; 3 (2): 103–111. 8. Ashton-Prolla P., Tong B., Shabbeer J., Astrin K. H., Eng C. M., Desnick R. J. Fabry disease: twenty-two novel mutations in the alpha-galactosidase A gene and genotype/phenotype correlations in severely and mildly affected hemizygotes and heterozygotes. J. Investig. Med . 2000; 48 (4): 227–235. 9. Knol I. E., Ausems M. G., Lindhout D., van Diggelen O. P., Ver- wey H., Davies J., Ploos van Amstel J. K., Poll-The B. T. Different phenotypic expression in relatives with fabry disease caused by a W226X mutation. Am. J. Med. Genet. 1999; 82 (5): 436–449. 10. Elleder M., Bradova V., Smid F., Budesinsky M., Harzer K., Kustermann-Kuhn B., Ledvinova J., Belohlavek X., Kral V., Dora zi lo- va V. Cardiocyte storage and hypertrophy as a sole manifestation of Fabry's disease. Virchows Arch. Pathol. Anat. Histopathol . 1990; 417: 449–455. Doi: 10.1007/BF01606034. 11. Nakao S., Takenaka T., Maeda M., Kodama C., Tanaka A., Tahara M., Yoshida A., Kuriyama M., Hayashibe H., Sakuraba H., Tanaka H. An atypical variant of Fabry's disease in men with left ventricular hypertrophy. N. Engl. J. Med . 1995; 333: 288–293. Doi: 10.1056/NEJM199508033330504. 12. Nakao S., Kodama C., Takenaka T., Tanaka A., Yasumoto Y., Yoshi da A., Kanzaki T., Enriquez A. L., Eng C. M., Tanaka H., Tei C., Des nick R. J. Fabry disease: detection of undiagnosed hemodialysis patients and identification of a «renal variant» phenotype. Kidney Int. 2003; 64: 801–807. Doi: 10.1046/j.1523-1755.2003.00160.x. 13. Wilcox W. R., Oliveira J. P., Hopkin R. J., Ortiz A., Banikazemi M., Feldt-Rasmussen U., Sims K., Waldek S., Pastores G. M., Lee P., Eng C. M., Marodi L., Stanford K. E., Breunig F., Wanner C., War- nock D. G., Lemay R. M., Germain D. P. Females with Fabry disease frequently have major organ involvement: lessons from the Fabry Registry. Mol. Genet. Metab . 2008; 93: 112–128. Doi: 10.1016/j. ymgme.2007.09.013. 14. Maier E. M., Osterrieder S., Whybra C., Ries M., Gal A., Beck M., Roscher A. A., Muntau A. C. Disease manifestations and inacti- va tion in heterozygous females with Fabry disease. Acta Paediatr. (Supp.) . 2006; 95: 30–38. Doi: 10.1080/08035320600618809. 15. Migeon B. R. X inactivation, female mosaicism, and sex diffe- rences in renal diseases. J. Am. Soc. Nephrol. 2008; 19: 2052– 2059. Doi: 10.1681/ASN.2008020198. 16. Hopkin R. J., Bissler J., Banikazemi M., Clarke L., Eng C. M., Ger main D. P., Lemay R., Tylki-Szymanska A., Wilcox W. R. Charac- te rization of Fabry Disease in 352 Pediatric Patients in the Fabry Registry. жүктеу/скачать 103,53 Kb. Достарыңызбен бөлісу:
|